TCM
GMAB icon

Tekla Capital Management’s Genmab GMAB Stock Holding History

Tekla Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-73,015
Closed -$2.4M – 193
2021
Q1 		$2.4M Sell
73,015
-185,657
-72% -$6.98M 0.08% 157
2020
Q4 		$10.5M Buy
258,672
+73,893
+40% +$2.76M 0.37% 79
2020
Q3 		$6.76M Buy
184,779
+168,259
+1,019% +$6.08M 0.25% 88
2020
Q2 		$560K Sell
16,520
-131,628
-89% -$3.59M 0.02% 210
2020
Q1 		$3.14M Buy
148,148
+131,628
+797% +$2.93M 0.14% 113
2019
Q4 		$369K Buy
+16,520
New +$361K 0.01% 199

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Tekla Capital Management's GMAB Position: Q2 2021 in Review

Tekla Capital Management sold out of Genmab (GMAB) in Q2 2021, closing a stake of 73,015 shares — an estimated $2.4M sold.

Tekla Capital Management first reported a position in GMAB in Q4 2019 and held it in 6 quarters. The position peaked at $10.5M in Q4 2020. 212 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

  • Tekla Capital Management reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
  • Tekla Capital Management sold 73,015 Genmab shares in Q2 2021, an estimated $2.4M.
  • Tekla Capital Management first reported a position in Genmab in Q4 2019 and held it in 6 quarters.
  • Tekla Capital Management's Genmab position peaked at $10.5M in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on Tekla Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.